689 related articles for article (PubMed ID: 17380777)
21. [Acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy treated with highly active anti-retroviral therapy].
Shimizu Y; Ota K; Takeuchi M; Iwata M; Yogo Y
Rinsho Shinkeigaku; 2000 Aug; 40(8):821-6. PubMed ID: 11218704
[TBL] [Abstract][Full Text] [Related]
22. [Genetic changes possibly associated with progressive multifocal leukoencephalopathy].
Yogo Y; Sugimoto C; Zheng HY; Kitamura T
Brain Nerve; 2007 Feb; 59(2):109-18. PubMed ID: 17380775
[TBL] [Abstract][Full Text] [Related]
23. [Progressive multifocal leukoencephalopathy in an elderly patient with no obvious immunosuppression].
Coşkun O; Sener K; Turhan V; Ongürü O; Gül HC; Eyigün CP
Mikrobiyol Bul; 2010 Jan; 44(1):141-7. PubMed ID: 20455411
[TBL] [Abstract][Full Text] [Related]
24. JC virus genotypes in France: molecular epidemiology and potential significance for progressive multifocal leukoencephalopathy.
Dubois V; Moret H; Lafon ME; Brodard V; Icart J; Ruffault A; Guist'hau O; Buffet-Janvresse C; Abbed K; Dussaix E; Ingrand D
J Infect Dis; 2001 Jan; 183(2):213-217. PubMed ID: 11110646
[TBL] [Abstract][Full Text] [Related]
25. Nucleic acid detection as a diagnostic tool in polyomavirus JC induced progressive multifocal leukoencephalopathy.
Dörries K; Arendt G; Eggers C; Roggendorf W; Dörries R
J Med Virol; 1998 Mar; 54(3):196-203. PubMed ID: 9515769
[TBL] [Abstract][Full Text] [Related]
26. JC virus load in progressive multifocal leukoencephalopathy: analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival, and the volume of neurological lesions.
García De Viedma D; Díaz Infantes M; Miralles P; Berenguer J; Marín M; Muñoz L; Bouza E
Clin Infect Dis; 2002 Jun; 34(12):1568-75. PubMed ID: 12032891
[TBL] [Abstract][Full Text] [Related]
27. The clinical features of PML.
Berger JR
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S8-12. PubMed ID: 22123935
[TBL] [Abstract][Full Text] [Related]
28. [Progressive multifocal leukoencephalopathy].
Hansen NJ; Madsen C; Stenager E
Ugeskr Laeger; 1995 Jan; 157(3):284-8. PubMed ID: 7846775
[TBL] [Abstract][Full Text] [Related]
29. [Progressive multifocal leukoencephalopathy (PML). Report of a case diagnosed by amplification of JC virus DNA from cerebrospinal fluid (CSF)].
Ito D; Yogo Y; Okita H; Tanaka K; Koto A
Rinsho Shinkeigaku; 1998 Jan; 38(1):46-50. PubMed ID: 9597910
[TBL] [Abstract][Full Text] [Related]
30. Progressive multifocal leukoencephalopathy--as a presenting manifestation of AIDS.
Raina S; Kaushal SS; Gupta D; Himral P; Sawal N; Sood V; Goyal A
J Assoc Physicians India; 2007 Nov; 55():797-801. PubMed ID: 18290557
[TBL] [Abstract][Full Text] [Related]
31. JC virus DNA in cerebrospinal fluid samples from Brazilian AIDS patients with focal brain lesions without mass effect.
Fink MC; Penalva de Oliveira AC; Milagres FA; Vidal JE; Picerno-Pouza AF; Duarte Neto A; Pannuti CS
J Infect; 2006 Jan; 52(1):30-6. PubMed ID: 16368458
[TBL] [Abstract][Full Text] [Related]
32. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.
Tantisiriwat W; Tebas P; Clifford DB; Powderly WG; Fichtenbaum CJ
Clin Infect Dis; 1999 May; 28(5):1152-4. PubMed ID: 10452651
[TBL] [Abstract][Full Text] [Related]
33. Improved detection of JC virus in AIDS patients with progressive multifocal leukoencephalopathy by T-antigen specific fluorescence resonance energy transfer hybridization probe real-time PCR: evidence of diverse JC virus genotypes associated with progressive multifocal leukoencephalopathy in Southern Africa.
Glass AJ; Venter M
J Med Virol; 2009 Nov; 81(11):1929-37. PubMed ID: 19774679
[TBL] [Abstract][Full Text] [Related]
34. JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy.
Koralnik IJ; Wüthrich C; Dang X; Rottnek M; Gurtman A; Simpson D; Morgello S
Ann Neurol; 2005 Apr; 57(4):576-80. PubMed ID: 15786466
[TBL] [Abstract][Full Text] [Related]
35. [Progressive multifocal leukoencephalopathy: virological and neuropathological aspects].
Ingrand D; Gray F
Arch Anat Cytol Pathol; 1997; 45(2-3):127-34. PubMed ID: 9382604
[TBL] [Abstract][Full Text] [Related]
36. Progressive multifocal leukoencephalopathy.
Berger JR; Major EO
Semin Neurol; 1999; 19(2):193-200. PubMed ID: 10718540
[TBL] [Abstract][Full Text] [Related]
37. Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy.
De Luca A; Giancola ML; Cingolani A; Ammassari A; Gillini L; Murri R; Antinori A
Clin Infect Dis; 1999 Mar; 28(3):624-8. PubMed ID: 10194089
[TBL] [Abstract][Full Text] [Related]
38. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy.
Koralnik IJ
J Neurovirol; 2002 Dec; 8 Suppl 2():59-65. PubMed ID: 12491153
[TBL] [Abstract][Full Text] [Related]
39. Progressive multifocal leukoencephalopathy.
Weissert R
J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
[TBL] [Abstract][Full Text] [Related]
40. Visual loss secondary to acquired immunodeficiency virus-related progressive multifocal leukoencephalopathy demonstrating clinical improvement with highly active antiretroviral therapy.
Diller R; Thompson K
Optometry; 2007 Feb; 78(2):63-70. PubMed ID: 17258160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
